Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessLazard Earns an Upgrade at Wolfe Research

Lazard Earns an Upgrade at Wolfe Research

Add to Favorite
Added to Favorite


Lazard (NYSE:LAZ) received an upgrade from Wolfe Research, shifting its rating from Underperform to Peer Perform. The firm raised its price target on the stock to $32 from $28 per share. The upgrade is based on expectations for the second quarter M&A activity.
The analysts noted that despite previous concerns, the stock’s discounted valuation compared to peers presents a more balanced risk/reward opportunity. Despite a 2% rise on Monday, the company’s shares have declined by 7% since the start of the year.
Furthermore, the analysts believe the company’s recent decision to reduce headcount will prove beneficial in the long run.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Lifecore Biomedical, Inc. (NASDAQ: LFCR) Quarterly Earnings Preview

Earnings per Share (EPS) loss is anticipated to be...

Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Faces Financial Challenges

Earnings per Share (EPS) of -$0.07 missed the estimated...

Arthur J. Gallagher & Co. (NYSE: AJG) Insider Purchase and Stock Performance

Gallagher Patrick Murphy, COO of Arthur J. Gallagher &...